PI-LBA09 ISOPSA: INITIAL CLINICAL PERFORMANCE EVALUATION OF A NOVEL STRUCTURE-BASED BIOMARKER FOR PROSTATE CANCER IN A MULTICENTER PROSPECTIVE TRIAL FOR GLEASON = 7 | Zendy

AI Assistant Blog Pricing

PI-LBA09 ISOPSA: INITIAL CLINICAL PERFORMANCE EVALUATION OF A NOVEL STRUCTURE-BASED BIOMARKER FOR PROSTATE CANCER IN A MULTICENTER PROSPECTIVE TRIAL FOR GLEASON = 7

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.